Abstract
The acute respiratory distress syndrome (ARDS) is characterized by progressive hypoxemia, decreased pulmonary compliance, and roentgenographic evidence of diffuse pulmonary infiltrates. The mechanisms that initiate, and then perpetuate the lung inflammation seen in ARDS remain poorly understood. Initially the syndrome was thought to involve only the lungs and to be the result of a single process; activation of the complement cascade. Subsequent investigations have shown that the injury is neither limited to the lungs nor is the pathogenesis simple. Neutrophil sequestration and migration within the lung remain histologic hallmarks of ARDS. It is likely that neutrophil recruitment and subsequent retention are the result of both chemotactic stimuli released within the lungs and activation of neutrophils by circulating mediators. Both complement components and lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, have been implicated as important agents in the induction of ARDS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Warren J, Johnson K, Ward P (1992) Immunoglobulin- and complement-mediated immune injury In: R Crystal, JB West (eds). Lung injury. Raven Press, New York, pp 179 – 186
Muller-Eberhard H (1984) The membrane attach complex. Springier Seminars. Immunopa-thology 7: 93 – 118
Craddock, PR, Fehr J, Dalmasso A, Brighham K, Jacob H (1977) Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membrane. J Clin Invest 59: 879 – 888
Craddock PR, Hammerschmidt DE, White JG, Dalmasso AP, Jacob AJ (1977) Complement (C5a)induced granulocyte aggregation in vitro: A possible mechanisms of complement-mediated leukostasis and leukopenia. J Clin Invest 60: 260 – 264
Till GO, Johnson KJ, Kunkel R (1982) Intravascular activation of complement and ALI: Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest 69: 1126 – 1135
Henson PM, Larsen GL, Webster RO, Mitchell BC, Goins AJ, Henson JE (1982) Pulmonary microvascular alterations and injury induced by complement fragments: Synergistic effect of complement activation, neutrophil sequestrations and prostaglandins. Ann NY Acad Sci 348: 287 – 300
Hosea S, Brown E, Hammer C, Frank M (1980) Role of complement activation in a model of adult respiratory distress syndrome. J Clin Invest 66: 375 – 382
Gelfand J, Donelan J, Hawiger A, Burke J (1982) Alternative complement pathway activation increases mortality in a model of burn injury in mice. J Clin Invest 70: 1170 – 1176
Parrish D, Mitchell B, Henson PM, Larsen G (1984) Pulmonary response of fifth component of complement-sufficient and deficient mice to hyperoxia. J Clin Invest 74: 956 – 965
Stevens, J, O’Hanley PT, Shapiro J, et al (1986) Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 77: 1812 – 1816
Rabinovic R, Yah C, Hillegass L, et al (1992) Role of complement in endotoxin/platelet activity factor induced lung injury. J Immunol 149: 1744 – 1750
Hammerschmidt D, Weaver L, Hudson L, Craddock PR, Jacob H (1980) Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome: Pathophysiological relevance and possible prognostic value. Lancet 1: 947 – 949
Duchteau J, Haas J, Schreyen H, et al (1984) Complement activation in patients at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis 130: 1058 – 1064
Langlois PF, Gawryl MS (1988) Accentuated formation of the terminal Cfb-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. Am Rev Respir Dis 138: 368 – 375
Parsons PE, Worthen G, Moore E, Tate R, Henson PM (1989) The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 140: 294 – 301
Parsons PE, Giclas PC (1990) The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 141: 98 – 103
Brigham K, Woolverton W, Glake L, et al (1974) Increased sheep lung vascular permeability caused by Pseudomonas bacteremia. J Clin Invest 54: 792 – 804
Brigham K, Bowers R, Haynes J (1979) Increased sheep lung vascular permeability caused by E. coll Endotoxin. Circulation 45: 292 – 297
Tobias PS, Ulevitch RJ (1983) Control of lipopolysaccharide-high density lipoprotein binding by acute phase proteins(s). J Immunol 131: 1913 – 1916
Tobias PS, Soldau K,, Ulevitch RJ (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164: 777 – 793
Schumann RR, Leong SR, Flaggs GW, et al (1990) Structure and function of lipopolysaccha ride binding protein. Science 249: 1429 – 1431
Wright S, Ramos R, Hermanowski-Vasatka A, Rockwell P, Detmers P (1991) Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14. J Exper Med 173: 1281 – 1286
Worthen G, Avdi N, Vukajlovich S, Tobias P (1993) Neutrophil adherence induced by lipopolysaccharide. J Clin Invest 90: 2526 – 2535
Wright S, Ramos R, Tobias P, Ulevitch RJ, Mathison JC (1990) CD14 a receptor for complexes of lipopolysaccharide (LPS) and LBP-binding protein. Science 249: 1431 – 1433
Maliszewski CR, Ball ED, Grazino RF, Fanger MW (1985) Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2–23. J Immunol 135: 1929 – 1935
Lynn WA, Liu Y, Golenbock DT (1993) Neither CD 14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect Immun 61: 4452 – 4461
Golenbock DT, Bach RR, Lichenstein H, Juan TSC, Tadavarthy A, Moldow CF (1995) Soluble CD 14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 125: 662 – 671
Gray PW, Flaggs G, Leong SR (1989) Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem 264: 9505 – 9509
Zhang JK, Morrison TK, Falk MC, Kang, YH, Lee CH (1996) Characterization of the binding of soluble CD14 to human endothelial cells and mechanisms for CD14-dependent cell activation by LPS. J Endotoxin 3: 307 – 315
Ramadori G, Meyer zum Buschenfelde KH, Tobias PS, Mathison JC, Ulevitch RJ (1990) Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology 58: 89 – 94
Martin TR, Mathison JS, Tobias PS, et al (1992) Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest 90: 2209 – 2219
Martin TR, Rubenfeld GD, Ruzinski JT et al (1997) Relationship between soluble CD 14, lipo-polysaccharide binding protein and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (In press)
Shasby DM, Fox RB, Harada RN, Repine JE (1982) Reduction of the edema of acute hyperox-ic lung injury by granulocyte depletion J Appi Physiol 52: 1237 – 1244
Rinaldo JE, Borovetz H (1985) Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am Rev Respir Dis 131: 579 – 583
Lo SK, Everitt J, Gu J, Malik AV (1992) Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest 89: 981 – 988
Windsor AC, Walsh CJ, Mullen PG, et al (1993) Tumor necrosis factor-alpha blockade prevents neutrophil CD 18 receptor up regulation and attenuates ALI in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 91: 1459 – 1468
Goodman RD, Strieter RM, Martin DP, et al (1996) Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154: 602 – 611
Steinberg KP, Milberg JA, Martin TR, et al (1994) Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 150: 113 – 122
Haslett CL, Guthrie LA, Kopaniak MM, Johnston RB, Henson PM (1985) Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119: 101 – 110
Worthen G, Hasslet C, Rees A, Gumbay R, Henson J, Henson PM (1987) Neutrophilmediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration within the lung. Am Rev Respir Dis 136: 19 – 28
Hasslet C, Worthen G, Giclas P, Morrison D, Henson J, Henson PM (1987) The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbits. Am Rev Respir Dis 136: 9 – 18
Donner RL, Elin RJ, Hossein SM, Wesley RA, Reilly JM, Parillo JE (1991) Endotoxin in human septic shock. Chest 99: 169 – 175
Fowler AA, fisher B, Center R, Carchman R (1983) Development of ARDS, progressive alteration of neutrophil chemotactic and secretory processes. Am J Path 166: 427 – 435
Parsons PE, Gillespie MK, Moore EE, Moore FA, Worthen GS (1995) Neutrophil response to endotoxin in the adult respiratory distress syndrome: Role of CD 14. Am J Respir Cell Mol Biol 13: 152 – 160
Guntheroth W, Lachter D, Kawaburi I (1982) Pulmonary microcirculation: Tubules rather than sheet and post. J Appi Physiol 53: 510 – 515
Erzurum S, Downey G, Schwab B, Elson D, Worthen GS (1992) Mechanisms of lipopolysac-charide-induced neutrophil retention. Relative contributions of adhesive and cellular me-chanical properties. J Immun 149: 154 – 162
Tonnesum JG, Anderson DC, Springer TA, Knedler A, Avdi N, Henson PM (1989) Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p-150.95 glycoprotein family. J Clin Invest 83: 637 – 646
Bevilacqua M, Nelson R (1993) Selectins. J Clin Invest 91: 379 – 387
Henson PM, Doherty DE, Riches DWH, Parsons PE, Worthen GS (1994) LPS, cytokines. In: Brigham KL (ed) Endotoxin and the lungs. Marcel Dekker, New York, NY pp 267 – 304
Kuan Df, Rust K, Crouch E (1992) Interactions of surfactant protein D with bacterial lipo-polysaccharides. J Clin Invest 90: 97 – 106
Van Iwaarden JF, Pikaar JC, Storm J, et al (1994) Binding of surfactant protein A to the lipid A moiety of lipopolysaccharides. Biochem J 303: 407 – 411
Pikaar JC, Voorhout WF, van Golde LMG, Verhoef J, Van Strijp JAG, van Iwaarden JF (1995) Opsonic activities of surfactant protein A and D in phagocytosis of Gram-negative bacteria by alveolar macrophages. J Infect Dis 172: 481 – 489
Greene KE, Wong VA, Mongovin SM, Goodman RB, Martin TR (1996) SP-A inhibits the bio-activity and release of IL-8. Am J Respir Crit Care Med 153: A662 (Abst)
Gregory TJ, Longmore WJ, Moxley MA, et al (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976 – 1981
Greene KE, Wright JR, Wong WB, et al (1995) Serial SP-A levels in BAL and serum of patients with ARDS. Am J Respir Crit Care 153: A587 (Abst)
McCall C, Grosso-Wilmouth L, LaRue K, Guzman R, Cousart S (1993) Tolerance to endotox-in-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91: 853 – 861
Alexander H, Sheppard B, Jensen J, et al (1991) Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram negative sepsis. J Clin Invest 88: 34 – 39
Mathison J, Walfson E, Ulevitch R (1988) Participation of tumor necrosis factor in the mediation of Gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81: 1925 – 1937
Munoz C, Carlet J, Fitting C, Misset B, Bierot J, Cavaillon J (1991) Dysregulation of in vitro cytokine production by monocytes in sepsis. J Clin Invest 88: 1747 – 1754
Mathison J, Virca G, Wolfson E, Tobias P, Glaser K, Ulevithch R (1990) Adaptation of bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 85: 1108 – 1118
Zuckerman S, Evans G, Snyder Y, Roeder W (1989) Endotoxin-macrophage interaction: Post-translational regulation of tumor necrosis factor expression. J Immunol 143: 1223 – 1227
Kimmings AN, Pajkrt D, Zaaijer K, et al (1996) Factors involved in early in vitro endotoxin hyporesponsiveness in human endotoxemia. J Endotoxin Research 3: 283 - 289
Fine J (1967) The intestinal circulation in shock. Gastroenterology 52: 454 – 460
Ziegler T, Smith R, O’Dwyer S, Demling, Wilmore D (1988) Increased intestinal permeability associated with infection in burn patients. Arch Surg. 123: 1313 – 1319
Moore F, Moore E, Jones T, et al (1989) TEN versus TPN following major abdominal trauma-reduced septic mortality. J Trauma 29: 916 – 23
Moore F, Moore E, Poggetti R, et al (1991) Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma. 31: 629 – 638
Roumen R, Hendriks T, Wevers R, Goris J (1993) Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 128: 453 – 457
Riddington, DW, Venkatesh B, Boivin CM, et al (1996) Intestinal permeability, gastric intra-mucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 275: 1007 – 1012
McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR (1994) Treatment of septic shock with human monoclonal antibody Ha-IA. Ann Inter Med 121: 1 - 5
Ziegler EJ, Fisher CJ, Sprung, et al (1991) Treatment of Gram-negative bacteremia and septic shock with Ha-IA human monoclonal antibody against endotoxin. N Engl J Med 324: 429 – 436
Baumgartner JD (1991) Immunotherapy with antibodies to core lipopolysaccharide: A critical appraisal. Infec Dis Clin North Am 5: 915 – 927
Baumgartner JD, Heumann D, Gerain J, Weinbreck P, Grau GE, Glauser MP (1990) Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alfa and interleukin 6. J Exp Med 171: 889 – 896
Manual of clinical laboratory immunology (1997) Rose NR et al. (eds) 5th ed. Washington, DC, ASM Press
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Greene, K.E., Parsons, P.E. (1998). Complement and Endotoxin in Lung Injury. In: Marini, J.J., Evans, T.W. (eds) Acute Lung Injury. Update in Intensive Care and Emergency Medicine, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60733-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-60733-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64532-7
Online ISBN: 978-3-642-60733-2
eBook Packages: Springer Book Archive